NCT00924170 2023-11-14Phase II Trial of LMB-2, Fludarabine and Cyclophosphamide for Adult T-Cell LeukemiaNational Institutes of Health Clinical Center (CC)Phase 1/2 Completed18 enrolled 30 charts